Dapagliflozin mitigates cellular stress and inflammation through PI3K/AKT pathway modulation in cardiomyocytes, aortic endothelial cells, and stem cell-derived β cells. - Alsereidi FR; Khashim Z; Marzook H; Al-Rawi AM; Salomon T; Almansoori MK; Madkour MM; Hamam AM; Ramadan MM; Peterson QP; Saleh MA (Cardiovascular diabetology, 2024)